Aura Minerals AUGO

Reference table

1. What it is

Aura Minerals Inc. (Nasdaq: AUGO) is a gold and copper producer focused on the Americas. Its operating footprint spans the Minosa mine (Honduras), the Apoena and Almas mines (Brazil), the Aranzazu copper-gold mine (Mexico), and the Borborema project (Brazil), plus exploration targeting gold, copper and silver deposits. Founded in 1946 (as Aura Gold, renamed Aura Minerals in 2007); CEO Rodrigo Cardoso Barbosa; ~1,413 employees; principal office in Coconut Grove, Florida; incorporated in the British Virgin Islands (ISIN VGG069731120). The company listed on the Nasdaq Global Market on 2025-07-16, raising ~$200M (FY25 common stock issuance $200.3M in the cash-flow statement) — so it has less than one year of US trading history.

Revenue mix — honest data gap: FMP supplies no product-segment or geographic-segment breakdown for AUGO (seg_prod and seg_geo are empty). We can name the mines but cannot quantify each mine's revenue share from this dataset; treat mine-level concentration as unmeasured rather than absent. What the filings-level data does show: FY25 revenue $921.7M at a 58.0% gross margin, i.e., a company whose economics are currently excellent at prevailing gold/copper prices.

2. The expert thesis (traceable)

No expert-panel coverage — this note is fundamentals-driven. A search of the Synthos knowledge base returns zero traceable claims on AUGO (0 voices, 0 claims). That is the honest house standard for screen-surfaced names: this company entered the pipeline via the quant momentum screen, not via expert conviction, and nothing below should be read as carrying panel endorsement.

Two consequences, stated plainly:

• Conviction is capped at Low. With no independent expert bull or bear thesis to weigh, the verdict rests entirely on reported financials, consensus estimates, and technicals — all from the FMP data pull dated 2026-07-06.
• The Street is thin too. Analyst grades show only 3 Buy ratings (0 Hold, 0 Sell) and the price-target block contains a single target: $52.80 (high, low, median and consensus are all the same number). Three buy ratings alongside a target 22% below the market price is an odd pairing — it most likely means the target is stale relative to the ratings, or vice versa. Either way, coverage this thin deserves a discount, and we flag rather than resolve the tension.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores summarize them.

Synthos fair value = the base case, ~$53 (−22%), essentially on top of the Street's $52.80 — in this case that is partly an anchor (per house policy for screen-surfaced names), but our independent 9× 2026E EV/EBITDA cross-check lands within $2 of it. The asymmetry is the verdict: +18% to the bull, −56% to the bear, −22% to base. You are being offered less upside than downside at $67.73. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). AUGO is neither — it is a cyclical volume ramp:

• Forward growth: consensus revenue $921.7M (FY25 actual) → $1.66B (2026E, +80%) → $2.09B (2027E, +26%) → $2.54B (2028E, +22%). Consensus EPS: $10.40 (2026E) → $11.39 → $14.40 → $15.80 (2029E) — but see §6 on why we distrust the EPS line.
• Acceleration (the 2nd derivative) is negative: +80% → +26% → +22% → −6% (2029E $2.39B) → +5% (2030E $2.51B). The explosive year is the current one; analysts then see the ramp plateauing as new mines reach run-rate. That is the opposite of the accelerating profile that earns an 8.
• Room to run: at $5.7B, a doubling requires either materially higher gold prices or new deposits not yet in the estimates — possible (exploration is the business), but not underwritable from this dataset.
• Reinvestment reality: capex is ~15% of revenue ($179.4M FY25) and capex/depreciation runs 2.1× — this is a capital-hungry build-out phase, the structural opposite of an asset-light exponential.

Exponential Potential: Moderate (4/10). Real growth, honestly scored as what it is: a mine-ramp-plus-commodity-price surge that consensus itself says flattens by 2029.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY25 $921.7M, +55.1% (FY24 $594.2M, which was +42.5% on FY23 $416.9M). The step-change is new Brazilian production meeting a strong gold tape.
• Quarterly trajectory (the ramp is real): Q1 2025 $161.8M → Q2 $190.4M → Q3 $247.8M → Q4 $321.7M → Q1 2026 $382.6M (+136.5% YoY). Q1 2026 EBITDA $181.3M; net income $95.2M (diluted EPS $1.15).
• Margins: gross 56.4% TTM (FY25 58.0%, up from 42.3% FY24); EBITDA margin 32.4% TTM; net margin just 7.8% TTM — the wedge between gross and net is interest, heavy D&A, derivative/FX items and a 63.4% TTM effective tax rate.
• Earnings quality — read carefully. FY25 GAAP net income was −$79.3M (EPS −$0.97) despite $534.9M of gross profit, destroyed by ~$402M of net other expenses (derivative/FX-type items; FMP's mapping of Aura's non-operating lines is noisy) and a $131.2M tax charge on only $51.9M of pretax income. The good news cuts the other way from most flattered names: income-quality ratio 3.9 — cash earnings run far above GAAP earnings. Underwrite the cash flow, not the EPS line, in either direction.
• Cash flow: FY25 operating CF $257.9M, capex −$179.4M, FCF $78.5M (FCF yield ~3.1% TTM). Note FY25 dividends paid were $115.8M — 1.5× FCF — bridged by the ~$200M IPO raise; TTM dividend payout is 171% of net income. The $2.25/sh dividend is real but not yet self-funding at this capex intensity.
• Balance sheet: cash $286.1M, total debt $411.2M, net debt $125.1M, net-debt/EBITDA 0.73× TTM — modest leverage vs earnings. But the equity base is thin: $265.7M total equity (retained earnings −$626.3M), financial leverage 5.4×, current ratio 0.98 / working capital −$9.9M — tight short-term liquidity for a company paying out this much cash. No goodwill/intangibles; PP&E is $945.4M of the $1.61B asset base.

6. Valuation — priced in or room?

Trailing numbers say expensive-with-an-asterisk: 61× trailing GAAP P/E (on depressed, noise-heavy GAAP earnings), 16.0× EV/EBITDA TTM, 5.2× EV/sales, 18.3× book (book is thin, so P/B overstates; tangible BVPS is $3.70). FMP's letter rating is B (overall 3/5: DCF score 5 and ROE 5, but debt-to-equity, P/E and P/B all score 1/5).

The forward line looks absurdly cheap — consensus 2026E EPS $10.40 puts the stock at ~6.5× forward — but we flag it as unreliable: 2026E consensus net income ($859.6M avg) exceeds 2026E consensus EBIT ($321.0M avg), which is only possible with enormous assumed non-operating gains or a data/estimate error, and only 3 analysts contribute EPS numbers (the 2030E EPS field is literally zero — a coverage gap, not a forecast). A more honest earnings yardstick: the adjusted EPS actual/estimate track — Q1 2026 actual $1.30 vs $2.18 estimated, next quarter estimated $1.54 — annualizes to roughly $5.5–6, i.e., ~11–12× current-year adjusted earnings. That is mid-tier-gold-producer territory, not a bargain, for a name at ~12× 2026E EV/EBITDA when the peer norm is closer to 6–9×.

Our anchor therefore sits on EV/EBITDA (9× 2026E → ~$51) corroborated by the lone Street target ($52.80). And note the estimate-accuracy record: three consecutive quarterly EPS misses (Q3 2025: $0.84 vs $0.97; Q4 2025: $0.96 vs $1.67; Q1 2026: $1.30 vs $2.18). The stock is priced ~28% above every valuation anchor we have.

7. Technicals (from the tech block)

• Trend: cracking. $67.73 is below the 50-DMA ($71.97) and above the 200-DMA ($61.04); MACD −1.96 (negative — momentum pointing down).
• Location: −37.9% off the 52-week high ($109.14) — that is also the max drawdown from peak — and +188% off the 52-week low ($23.50), which dates to the July 2025 listing period. A massive post-IPO run that has given back a large chunk.
• Momentum: RSI(14) 59.9 — neutral; today's +3.5% bounce is inside a downtrend, not a reversal signal by itself.
• Relative strength (the tell): 3-mo −22.8% vs SPY +14.6% and QQQ +23.6% — severe recent underperformance; 6-mo still +34.3% vs SPY +10.2%. 12-mo return is not available (listed on Nasdaq less than a year — an honest data gap, not an omission).
• Read: technicals are deteriorating — a broken momentum leader below its 50-DMA with negative MACD. For a Watch name that is fine: the 200-DMA (~$61) and our ~$53 trigger are the levels that matter. No technical urgency to act.

8. Moat & competitive position

Commodity producers do not have moats in the franchise sense — they have cost position, mine life, and jurisdiction. From this dataset we can say: Aura's current cost position looks competitive (56–58% gross margins at prevailing prices; operating return on assets 34.5% TTM), its growth pipeline (Almas ramping, Borborema building) is what differentiates it from static mid-tiers, and its diversification across four operating assets in three countries reduces single-mine risk while adding Honduras and Mexico jurisdiction risk most large-cap peers avoid. What we cannot quantify from the data: reserve life, AISC per ounce, or hedge-book position — all central to a miner's quality and all absent from this pull. Flagged, not guessed.

Peer set (FMP-supplied, market cap): a mixed basic-materials bag rather than clean gold comps — Century Aluminum $4.6B, Elevra Lithium $5.3B, Endeavour Silver $2.5B, Fortuna Mining $2.6B, Hawkins $2.9B, Perpetua Resources $2.6B, Tecnoglass $2.0B, TMC $1.8B, Titan America $3.4B, Americas Gold & Silver $1.4B. The most relevant comparators (mid-tier gold producers like Eldorado, Alamos, Lundin Gold) are not in this supplied set — judge AUGO against the gold-producer cohort, not this heterogeneous list. Among names shown, only Fortuna, Endeavour and Americas G&S are genuine precious-metals producers, and all trade at fractions of AUGO's market cap.

9. Management, capital allocation & guidance

• Capital allocation: aggressive on both ends — FY25 saw $179.4M capex (the growth build) and $115.8M of dividends (vs $78.5M FCF), funded by the ~$200.3M Nasdaq IPO raise; buybacks negligible ($0.4M). Paying a 1.5×-FCF dividend during a capex peak is a bold shareholder-return statement that only stays affordable if gold cooperates.
• Insider activity — the flag of this note. A genuine selling cluster in the last two weeks: COO Glauber Rosa Luvizotto sold 43,677 shares across 2026-06-26, 07-01 and 07-02 at ~$65.00–65.27; CFO Joao Kleber Dos Santos Cardoso sold ~59,000 shares on 2026-06-30 at $61.08–62.90 (three Form 4 tranches); director Bruno Sousa Mauad also disposed of 26,573 BDRs on 06-30. Two named executive officers selling within days of each other, right after a −38% drawdown began, is a materially worse tell than a single routine 10b5-1 sale — we weight it accordingly in the risk score.
• Management guidance: no earnings-call transcript or guidance text is included in this data pull, and with no KB claims there is no management voice to quote. The only forward markers we have are the consensus estimates and the 2026-08-05 earnings date (Street: EPS $1.54, revenue ~$370.2M). Honest gap, stated as such.

10. Catalysts & what to watch

• Next earnings: 2026-08-05 (Q2 2026; Street EPS $1.54, revenue ~$370.2M). The company has missed the EPS estimate three quarters running — a fourth miss into a broken tape likely accelerates the de-rate toward our trigger; a clean beat would force us to revisit the estimate-quality caveats.
• Gold and copper prices: the dominant exogenous driver of every line in this model. A sustained gold correction is the bear case's engine.
• Borborema / Almas ramp milestones: the volume half of the thesis — commissioning pace, throughput, and (when disclosed) cash costs.
• Insider filings: whether the June–July officer selling continues, stops, or reverses. More Form 4 sales below $65 would harden the negative read.
• Dividend sustainability: FY26 FCF vs the $2.25/sh payout — a cut would crack the income-buyer bid; self-funding coverage would remove a key bear point.
• Estimate revisions: whether the internally-inconsistent 2026E consensus (net income > EBIT) gets cleaned up as more analysts pick up coverage post-IPO.

Thesis tripwires (what would change the call): price reaching ~$53 with gold prices intact and the Q2 print not disastrous (upgrades Watch → candidate Buy — Tactical); conversely, a dividend cut, a Borborema setback, or a fourth straight big EPS miss would push the trigger price down, not make us buy the dip.

11. Key risks

• Commodity price (the dominant risk): revenue, margins, dividend capacity and the multiple all lever off gold (plus copper at Aranzazu). There is no hedge-book disclosure in this dataset to size the protection.
• Valuation: ~28% above the base fair value and the lone Street target, at ~12× 2026E EV/EBITDA vs a 6–9× peer norm — the de-rating can finish the job it started in Q2.
• Insider selling: COO + CFO cluster in late June/early July at $61–65; if management won't hold it at $65, the market may ask why it should at $68.
• Jurisdiction: Honduras, Mexico, Brazil — permitting, royalty/tax regimes (note the 63% TTM effective tax rate) and political risk are structurally higher than North-American-only peers.
• Liquidity & structure: current ratio 0.98, equity base $266M against $411M debt, <1 year of Nasdaq trading history, and a dividend running ahead of FCF.
• Estimate quality: 3-analyst EPS coverage, internally inconsistent 2026E figures, a zeroed-out 2030E EPS field, and three straight misses — the "cheap forward P/E" is not underwritable.
• Data gaps (named honestly): no segment/geography revenue split, no AISC or reserve data, no transcript/guidance, no 12-month return series, no expert-panel coverage.

12. Verdict, position sizing & monitoring

Watch. The business itself is performing: +136% YoY quarterly revenue growth, 56% gross margins, ROIC ~17%, modest net leverage (0.73× EBITDA), and a real dividend. If we could buy that at the right price, we would want to. But every anchor we trust — the lone Street target ($52.80), our 9× 2026E EV/EBITDA cross-check (~$51), the adjusted-earnings run-rate (~11–12×) — says fair value is in the low $50s, roughly 22% below the market. Add a broken tape (below the 50-DMA, −23% in 3 months against a +15% market), three consecutive EPS misses, a dividend outrunning FCF, and the COO and CFO selling stock two weeks ago, and there is no honest case for paying $67.73 today. We want the business, not this price.

• Sizing: none now. If AUGO pulls back to the ~$53 trigger with gold prices intact and the 2026-08-05 print not thesis-breaking, a starter ~0.5–1.5% position in the commodity sleeve is the plan — sized for a name that has already shown a −38% drawdown and can do it again.
• Monitoring: re-underwrite on the §10 tripwires; formal re-score at the Q2 print (2026-08-05). This verdict is logged as a tracked Synthos call as of 2026-07-06 at $67.73.
• Single biggest risk to the Watch stance itself: gold keeps ripping and the ramp beats — in which case we will have missed upside by waiting for a price that never comes. We accept that risk; the asymmetry at $68 (−56% bear vs +18% bull) says patience is the positive-expected-value play.

Provenance & disclosures

• Traceability: 0 KB claims, 0 voices — no expert-panel coverage exists for AUGO; nothing in this note carries panel conviction, and kb_net_conviction is null rather than invented. This name was surfaced by the quant momentum screen and analyzed from fundamentals alone.
• Data as-of: fundamentals 2026-03-31 (Q1 2026, filed 2026-05-07) · estimates & prices 2026-07-06 · insider filings through 2026-07-06. Forward figures are analyst consensus (FMP), labeled as estimates.
• Estimate-quality caveat: consensus EPS/net-income lines are internally inconsistent (2026E net income > 2026E EBIT), rest on as few as 1–5 analysts, and show a zeroed 2030E EPS field; our valuation anchors on EV/EBITDA and the Street target instead, with multiples labeled as our own assumptions.
• Data-gap caveats: no segment or geographic revenue split supplied (seg_prod/seg_geo empty); no AISC, reserve-life or hedge-book data; no earnings-call transcript; 12-month return unavailable (Nasdaq listing 2025-07-16). Where a figure is absent we say so rather than estimate it.
• Peer caveat: the FMP-supplied peer list is a heterogeneous basic-materials set that omits the most relevant mid-tier gold producers; judge against that cohort.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-06. Prior versions available via the deep-dive version dropdown ("based on the info at the time").